We are live on ! Find out more
HIIFS

Harel Insurance Investments & Financial Services Portfolio holdings

AUM $20.6B
1-Year Est. Return 59.59%
This Fund
S&P 500
This Quarter Est. Return
-4.29%
1 Year Est. Return
+59.59%
3 Year Est. Return
+125.92%
5 Year Est. Return
+132.08%
10 Year Est. Return
+569.36%
AUM
$835M
AUM Growth
-$27.8M
Cap. Flow
-$83.4M
Cap. Flow %
-9.99%
Top 10 Hldgs %
55.72%
Holding
466
New
70
Increased
59
Reduced
104
Closed
93

Top Buys

Rank Stock Value
1
PPH icon
VanEck Pharmaceutical ETF
PPH
+$12.8M
2
VRNT
Verint Systems
VRNT
+$2.67M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.44M
4
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$1.25M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.03M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$55.8M
2
NICE icon
Nice
NICE
+$12.5M
3
VPL icon
Vanguard FTSE Pacific ETF
VPL
+$8.47M
4
EOG icon
EOG Resources
EOG
+$4.98M
5
HEDJ icon
WisdomTree Europe Hedged Equity Fund
HEDJ
+$2.52M

Sector Composition

Rank Sector Weight
1 Financials 13.29%
2 Healthcare 11.29%
3 Technology 5.23%
4 Energy 4.56%
5 Communication Services 3.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMDX
451
Insight Molecular Diagnostics
IMDX
$147M
$0 ﹤0.01%
+4
New +$354
PCY icon
452
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.39B
– –
-10,000
Closed -$273K
SPLV icon
453
Invesco S&P 500 Low Volatility ETF
SPLV
$7.18B
– –
-6,700
Closed -$258K
UBR icon
454
ProShares Ultra MSCI Brazil Capped
UBR
$3.39M
– –
-500
Closed -$13K
XPH icon
455
State Street SPDR S&P Pharmaceuticals ETF
XPH
$510M
– –
-560
Closed -$29K
MNDT
456
DELISTED
Mandiant, Inc. Common Stock
MNDT
– –
-3,085
Closed -$64K
PNTR
457
DELISTED
Pointer Telocation Ltd.
PNTR
$0 ﹤0.01%
+1
New +$6
UMX
458
DELISTED
ProShares Ultra MSCI Mexico Capped IMI
UMX
– –
-700
Closed -$17K
IST
459
DELISTED
SPDR S&P International Telecommunications Sector
IST
– –
-600
Closed -$15K
MEG
460
DELISTED
Media General, Inc
MEG
– –
-1,000
Closed -$16K
CRC
461
DELISTED
California Resources Corporation
CRC
$0 ﹤0.01%
+31
New +$366
FTW
462
DELISTED
First Trust Taiwan AlphaDEX Fund
FTW
– –
-2,100
Closed -$60K
QLIK
463
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
– –
-400
Closed -$13K
NORW
464
DELISTED
Global X MSCI Norway ETF
NORW
– –
-500
Closed -$5K
15 16 17 18
19

Similar funds

CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return

Harel Insurance Investments & Financial Services's Q1 2016 Portfolio in Review

As of Q1 2016, Harel Insurance Investments & Financial Services held 466 positions worth $835M, down 3.2% from $863M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Harel Insurance Investments & Financial Services withdrew a net $83.4M in Q1 2016, closing 93 positions and reducing 104 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $55.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Harel Insurance Investments & Financial Services opened a new position in VanEck Pharmaceutical ETF worth $12.4M.

  • Harel Insurance Investments & Financial Services's largest Q1 2016 buy was VanEck Pharmaceutical ETF: 215,790 shares worth $12.4M.
  • Harel Insurance Investments & Financial Services added most to Verint Systems in Q1 2016, an estimated $2.67M increase.
  • Harel Insurance Investments & Financial Services's biggest Q1 2016 reduction was Vanguard FTSE Pacific ETF, cutting an estimated $8.47M.
  • Harel Insurance Investments & Financial Services fully exited Teva Pharmaceuticals in Q1 2016, selling an estimated $55.8M.
  • Harel Insurance Investments & Financial Services's ten largest holdings make up 56% of its $835M portfolio in Q1 2016.
  • Harel Insurance Investments & Financial Services opened 70 new positions and closed 93 in Q1 2016.
  • Harel Insurance Investments & Financial Services's portfolio value fell 3.2% quarter-over-quarter to $835M.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2016, filed 2 May 2016.